Literature DB >> 25187549

Recent population expansions of hepatitis B virus in the United States.

Sumathi Ramachandran1, Michael A Purdy2, Guo-liang Xia2, David S Campo2, Zoya E Dimitrova2, Eyasu H Teshale2, Chong Gee Teo2, Yury E Khudyakov2.   

Abstract

UNLABELLED: The recent epidemic history of hepatitis B virus (HBV) infections in the United States is complex, as indicated by current disparity in HBV genotype distribution between acute and chronic hepatitis B cases and the rapid decline in hepatitis B incidence since the 1990s. We report temporal changes in the genetic composition of the HBV population using whole-genome sequences (n = 179) from acute hepatitis B cases (n = 1,206) identified through the Sentinel County Surveillance for Acute Hepatitis (1998 to 2006). HBV belonged mainly to subtypes A2 (75%) and D3 (18%), with times of their most recent common ancestors being 1979 and 1987, respectively. A2 underwent rapid population expansions in ca. 1995 and ca. 2002, coinciding with transient rises in acute hepatitis B notification rates among adults; D3 underwent expansion in ca. 1998. A2 strains from cases identified after 2002, compared to those before 2002, tended to cluster phylogenetically, indicating selective expansion of specific strains, and were significantly reduced in genetic diversity (P = 0.001) and frequency of drug resistance mutations (P = 0.001). The expansion of genetically close HBV A2 strains was associated with risk of infection among male homosexuals (P = 0.03). Incident HBV strains circulating in the United States were recent in origin and restricted in genetic diversity. Disparate transmission dynamics among phylogenetic lineages affected the genetic composition of HBV populations and their capacity to maintain drug resistance mutations. The tendency of selectively expanding HBV strains to be transmitted among male homosexuals highlights the need to improve hepatitis B vaccination coverage among at-risk adults. IMPORTANCE: Hepatitis B virus (HBV) remains an important cause of acute and chronic liver disease globally and in the United States. Genetic analysis of HBV whole genomes from cases of acute hepatitis B identified from 1998 to 2006 in the United States showed dominance of genotype A2 (75%), followed by D3 (18%). Strains of both subtypes were recent in origin and underwent rapid population expansions from 1995 to 2000, indicating increase in transmission rate for certain HBV strains during a period of decline in the reported incidence of acute hepatitis B in the United States. HBV A2 strains from a particular cluster that experienced the most recent population expansion were more commonly detected among men who have sex with men. Vaccination needs to be stepped up to protect persons who remain at risk of HBV infection.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25187549      PMCID: PMC4249146          DOI: 10.1128/JVI.01594-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Outbreak of hepatitis B in a nursing home associated with capillary blood sampling.

Authors:  J M Dreesman; A Baillot; L Hamschmidt; M Monazahian; U C Wend; W H Gerlich
Journal:  Epidemiol Infect       Date:  2006-01-26       Impact factor: 2.451

2.  Difference of HBV genotype distribution between acute hepatitis and chronic hepatitis in Japan.

Authors:  Y Takeda; Y Katano; K Hayashi; T Honda; S Yokozaki; I Nakano; M Yano; K Yoshioka; H Toyoda; T Kumada; H Goto
Journal:  Infection       Date:  2006-08       Impact factor: 3.553

3.  Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.

Authors:  Omana V Nainan; Miriam J Alter; Deanna Kruszon-Moran; Feng-Xiang Gao; Guoliang Xia; Geraldine McQuillan; Harold S Margolis
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

4.  Molecular evolution of hepatitis B virus over 25 years.

Authors:  Carla Osiowy; Elizabeth Giles; Yasuhito Tanaka; Masashi Mizokami; Gerald Y Minuk
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

5.  Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs.

Authors:  Susan T Goldstein; Miriam J Alter; Ian T Williams; Linda A Moyer; Franklyn N Judson; Karen Mottram; Michael Fleenor; Patricia L Ryder; Harold S Margolis
Journal:  J Infect Dis       Date:  2002-02-28       Impact factor: 5.226

6.  A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.

Authors:  Eric E Mast; Cindy M Weinbaum; Anthony E Fiore; Miriam J Alter; Beth P Bell; Lyn Finelli; Lance E Rodewald; John M Douglas; Robert S Janssen; John W Ward
Journal:  MMWR Recomm Rep       Date:  2006-12-08

7.  Widespread dissemination in England of a stable and persistent hepatitis B virus variant.

Authors:  Rachel L Hallett; Siew Lin Ngui; Rolf E Meigh; Ken J Mutton; Elizabeth H Boxall; Chong Gee Teo
Journal:  Clin Infect Dis       Date:  2004-09-10       Impact factor: 9.079

Review 8.  Genotypes and genetic variability of hepatitis B virus.

Authors:  Anna Kramvis
Journal:  Intervirology       Date:  2014-07-15       Impact factor: 1.763

9.  Incidence of acute hepatitis B--United States, 1990-2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-01-02       Impact factor: 17.586

10.  The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies.

Authors:  M J Alter; S C Hadler; H S Margolis; W J Alexander; P Y Hu; F N Judson; A Mares; J K Miller; L A Moyer
Journal:  JAMA       Date:  1990-03-02       Impact factor: 56.272

View more
  8 in total

1.  Recent and occult hepatitis B virus infections among blood donors in the United States.

Authors:  Sumathi Ramachandran; Jamel A Groves; Guo-Liang Xia; Paula Saá; Edward P Notari; Jan Drobeniuc; Amanda Poe; Natasha Khudyakov; Sarah F Schillie; Trudy V Murphy; Saleem Kamili; Chong-Gee Teo; Roger Y Dodd; Yury E Khudyakov; Susan L Stramer
Journal:  Transfusion       Date:  2018-11-30       Impact factor: 3.157

2.  Characterization of Acute and Chronic Hepatitis B Virus Genotypes in Canada.

Authors:  Carla Osiowy; Elizabeth Giles; Max Trubnikov; Yogesh Choudhri; Anton Andonov
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

3.  Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial.

Authors:  Chunfeng Qu; Taoyang Chen; Chunsun Fan; Qimin Zhan; Yuting Wang; Jianhua Lu; Ling-ling Lu; Zhengping Ni; Fei Huang; Hongyu Yao; Jian Zhu; Jian Fan; Yuanrong Zhu; Zhiyuan Wu; Guoting Liu; Wenhong Gao; Mengya Zang; Dongmei Wang; Min Dai; Chu Chieh Hsia; Yawei Zhang; Zongtang Sun
Journal:  PLoS Med       Date:  2014-12-30       Impact factor: 11.069

4.  Efficient detection of viral transmissions with Next-Generation Sequencing data.

Authors:  Inna Rytsareva; David S Campo; Yueli Zheng; Seth Sims; Sharma V Thankachan; Cansu Tetik; Jain Chirag; Sriram P Chockalingam; Amanda Sue; Srinivas Aluru; Yury Khudyakov
Journal:  BMC Genomics       Date:  2017-05-24       Impact factor: 3.969

Review 5.  Antiviral drug resistance as an adaptive process.

Authors:  Kristen K Irwin; Nicholas Renzette; Timothy F Kowalik; Jeffrey D Jensen
Journal:  Virus Evol       Date:  2016-06-10

6.  Convex hulls in hamming space enable efficient search for similarity and clustering of genomic sequences.

Authors:  David S Campo; Yury Khudyakov
Journal:  BMC Bioinformatics       Date:  2020-12-30       Impact factor: 3.169

7.  Phylogenetic Analysis of Hepatitis B Virus Genotypes Circulating in Different Risk Groups of Panama, Evidence of the Introduction of Genotype A2 in the Country.

Authors:  Alexander A Martínez; Yamitzel Zaldívar; Griselda Arteaga; Zoila de Castillo; Alma Ortiz; Yaxelis Mendoza; Omar Castillero; Juan A Castillo; Juan Cristina; Juan M Pascale
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

Review 8.  Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy.

Authors:  Carla Osiowy; Carla Coffin; Anton Andonov
Journal:  Curr Treat Options Infect Dis       Date:  2016-07-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.